Schizophrenia Research
Volume 44, Issue 3 , Pages 233-243 , 1 September 2000

The hypothalamic–pituitary–thyroid axis in patients with schizophrenia

  • Andreas Baumgartner

      Affiliations

    • Department of Nuclear Medicine, Klinikum Benjamin Franklin, Free University of Berlin, Hindenburgdamm 30, 12203 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-30-8445-2727; fax: +49-30-8445-2700
    • ,
  • Adolf Pietzcker

      Affiliations

    • Department of Psychiatry, Klinikum Benjamin Franklin, Free University of Berlin, Berlin, Germany
    • ,
  • Wolfgang Gaebel

      Affiliations

    • Department of Psychiatry, University of Düsseldorf, Düsseldorf, Germany

Received 11 June 1999 ,Accepted 17 September 1999.

References 

  1. American Psychiatric Association . DSM-III: Diagnostic and Statistical Manual of Mental Disorders. third ed.. Washington, DC: American Psychiatric Association; 1987;
  2. Asher R. Myxoedematous madness. Br. Med. J. 1949;1:555–562
  3. Ashford A, Ross JW. Toxicity of depressant and antidepressant drugs in hyperthyroid mice. Br. Med. J. 1968;2:217–218
  4. Balon R, Pohl R, Yeragani VK, Ramesh C, Glitz DA. The changes of thyroid hormone during pharmacological treatment of panic disorder patients. Prog. Neuro-Psychoph. Biol. Psychiat. 1991;15:595–600
  5. Bauer M, Priebe S, Kürten I, Gräf KJ, Baumgartner A. Psychological and endocrine abnormalities in refugees from East Germany. Part I: Prolonged stress, psychopathology and hypothalamic–pituitary–thyroid axis activity. Psychiatry Res. 1993;51:61–73
  6. Baumgartner A, Gräf KJ, Kürten I, Meinhold H. The hypothalamic– pituitary –thyroid axis in psychiatric patients and healthy subjects. Part II: Repeated measurements of thyroxine, free thyroxine, triiodothyronine, free triiodothyronine and reverse triiodothyronine in patients with major depressive disorder and schizophrenia and healthy subjects. Psychiatry Res. 1988;24:283–305
  7. Baumgartner A, Gräf KJ, Kürten I, Meinhold H. The hypothalamic–pituitary–thyroid axis in psychiatric patients and healthy subjects. Part IV: TRH-tests, thyroxine, triiodothyronine, and reverse triiodothyronine determinations in medical students during a major examination. Psychiatry Res. 1988;24:316–332
  8. Baumgartner A, Dietzel M, Saletu B, Wolf R, Campos-Barros A, Gräf KJ, et al. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone and estradiol in healthy young women. Psychiatry Res. 1993;48:153–178
  9. Baumgartner A, Rommelspacher H, Otto M, Schmidt LG, Kürten I, Gräf KJ, et al. Hypothalamic–pituitary–thyroid (HPT) axis in chronic alcoholism. I: HPT axis in chronic alcoholics during withdrawal and after 3 weeks of abstinence. Alcohol Clin. Exp. Res. 1994;2:284–294
  10. Baumgartner A, Dubeyko M, Campos-Barros A, Eravci M, Meinhold H. Subchronic administration of fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain. Brain Res. 1994;635:68–74
  11. A. Baumgartner, Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research, Int. J. Clin. Psychopharmacol., (in press).
  12. Baumgartner A, Pinna G, Hiedra L, Gaio U, Hessenius C, Campos-Barros A, et al. Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology. 1997;16:25–41
  13. Breyer U, Müller-Oerlinghausen B, Mauruschat W. Phenothiazines with piperazine side chains. In:  Forrest JS,  Usdin E editor. Psychotherapeutic Drugs. New York: Marcel Dekker; 1977;p. 755–793
  14. Breyer-Pfaff U, Brinkschulte M, Rein W, Scheid HW, Straube E. Prediction and evaluation criteria in perazine therapy of acute schizophrenics: pharmacokinetic data. Pharmacopsychiatry. 1983;16:160–165
  15. Bursten B. Psychoses associated with thyrotoxicosis. Arch. Gen. Psychiatry. 1961;4:267–273
  16. Campos-Barros A, Meinhold H, Stula M, Müller F, Köhler R, Eravci M, et al. The influence of desipramine on thyroid hormone metabolism in rat brain. J. Pharmacol. Exp. Ther. 1994;268:1143–1152
  17. Campos-Barros A, Meinhold H, Köhler R, Müller F, Eravci M, Baumgartner A. The effects of desipramine on thyroid hormone concentrations in rat brain. Naunyn Schmiedeberg's Arch. Pharm. 1995;353:469–474
  18. Crocker AD, Overstreet DH. Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status. Psychopharmacology. 1984;82:102–106
  19. Engström G, Strömbom U, Svensson TH, Waldeck B. Brain monoamine synthesis and receptor sensitivity after single or repeated administration of thyroxine. J. Neural. Transm. 1975;37:1–10
  20. Eravci M, Pinna G, Meinhold H, Baumgartner A. Effects of pharmacological and nonpharmacological treatments of thyroid hormone metabolism and concentrations in rat brain. Endocrinology. 1999;in press
  21. Fishman SM, Sheehan DV, Carr DB. Thyroid indices in panic disorder. J. Clin. Psychiatry. 1985;46:432–433
  22. Guy W, Bonato RR. Clinical global impressions. In: Manual for the ECDEU Assessment Battery. second ed.. Rockville, MD: National Institute of Mental Health; 1970;
  23. Hall RCW, Stickney S, Beresford TP. Endocrine disease and behavior. Integr. Psychiatry. 1986;4:122–135
  24. Hoffmann WH, Chodoroff G, Pigott LR. Haloperidol and thyroid storm. Am. J. Psychiatry. 1978;135:484–486
  25. Joffe RT, Singer W. The effect of tricyclic antidepressants on basal thyroid hormone levels in depressed patients. Pharmacopsychiatry. 1990;23:67–69
  26. Joyce PR. The prognostic significance of thyroid function in mania. J. Psychiatr. Res. 1991;25:1–6
  27. Kirkegaard C, Bjørum N, Cohn D, Lauridsen UB. Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness. Arch. Gen. Psychiatry. 1978;35:1017–1021
  28. Kirkegaard C, Faber J. Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression. Acta Endocrinol. 1981;96:199
  29. Lake CR, Fann WE. Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism. Br. J. Psychiatry. 1973;123:523–525
  30. Leonard JL, Köhrle J. Intracellular pathways of iodothyronine metabolism. In:  Braverman LE,  Utiger RD editor. Werner and Ingbars's The Thyroid: a fundamental and clinical text,. seventh ed.. Philadelphia: Lippincott-Raven; 1996;p. 125–161
  31. Lesser IM, Rubin RT, Lydiard RB, Swinson R, Pecknold J. Past and current thyroid function in subjects with panic disorder. J. Clin. Psychiatry. 1987;48:473–476
  32. Loosen PT, Garbutt JC, Prange AJ. Evaluation of diagnostic utility of the TRH-induced TSH response in psychiatric disorders. Pharmacopsychiatry. 1987;20:90–95
  33. Mason JW, Kennedy JL, Kosten TR, Giller EL. Serum thyroxine levels in schizophrenic and affective disorder diagnostic subgroups. J. Nerv. Ment. Dis. 1989;177:351–358
  34. McLarty DG, Ratcliffe WA, Ratcliffe JG, Shimmins JG, Goldberg A. A study of thyroid function in psychiatric in-patients. Br. J. Psychiatry. 1978;133:211–218
  35. Morley JE, Shafer RB. Thyroid function screening in new psychiatric admissions. Arch. Intern. Med. 1982;142:591–593
  36. Munjack DJ, Palmer R. Thyroid hormones in panic disorder, panic disorder with agoraphobia, and generalized anxiety disorder. J. Clin. Psychiatry. 1988;49:229–231
  37. Naber D, Steinböck H, Greil W. Effects of short- and long-term neuroleptic treatment on thyroid function. Prog. Neuro-Psychopharmacol. 1980;4:199–206
  38. Nicoloff JT, LoPresti JS. Non-thyroidal illness. In:  Bravermann LE,  Utiger RD editor. Werner and Ingbars's The Thyroid: a fundamental and clinical text,. seventh ed.. Philadelphia: Lippincott-Raven; 1996;p. 288–296
  39. Oppenheimer JH, Schwartz HL, Strait KA. The molecular basis of thyroid hormone actions. In:  Bravermann LE,  Utiger RD editor. Werner and Ingbars's The Thyroid: a fundamental and clinical text,. seventh ed.. Philadelphia: Lippincott-Raven; 1996;p. 162–184
  40. Opstad PK. Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men. Eur. J. Endocrinol. 1994;131:56–66
  41. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol. Rep. 1962;10:799–812
  42. Park S, Happy JM, Prange AJ. Thyroid action on behavioral-physiological effects and disposition of phenothiazines. Eur. J. Pharmacol. 1972;19:357–365
  43. Pietzcker A, Gaebel W, Köpcke W, Linden M, Müller P, Müller-Spahn F, et al. Intermittent versus maintenance neuroleptic long-term treatment in schizophrenia: 2-year results of a German multicenter study. J. Psychiat. Res. 1993;27:321–339
  44. Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Gräf KJ, et al. Elevated 3,5-diiodothyronine concentrations in the sera of patients with non-thyroidal illnesses and brain tumors. J. Clin. Endocrinol. Metab. 1997;82:1535–1542
  45. Pinna G, Heidra L, Meinhold H, Eravci M, Prengel H, Brödel O, et al. 3,3-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors, and of healthy subjects during acute stress. J. Clin. Endocrinol. Metab. 1998;83:3071–3077
  46. Prange AJ, Lipton MA, Love GN. Diminution of imipramine mortality in hypothyroid mice. Nature. 1963;197:1212–1213
  47. Prange AJ, Loosen PT, Wilson IC, Meltzer HY, Fang VS. Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin). Arch. Gen. Psychiatry. 1979;36:1086–1093
  48. Rinieris P, Christodoulou GN, Souvatzglou A, Koutras DA, Stefanis C. Free-thyroxine index in mania and depression. Compr. Psychiatry. 1978;19:561–564
  49. Rinieris P, Christodoulou GN, Souvatzglou A, Koutras DA, Stefanis C. Free-thyroxine index in schizophrenic patients before and after neuroleptic treatment. Neuropsychobiology. 1980;6:29–33
  50. Roca RP, Blackman MR, Ackerley MB, Harman SM, Gregerman RI. Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocrinol. Res. 1990;16:415–447
  51. Roy A, Wolkowitz O, Doran A, Pickar D. TRH test in schizophrenic patients and controls. Biol. Psychiatry. 1989;25:523–526
  52. Skobba T, Miya TS. Hyperthermic responses and toxicity of chlorpromazine in L-thyroxine sodium-treated rats. Toxicol. Appl. Pharm. 1969;14:176–181
  53. Soboll S. Thyroid hormone action on mitochondrial energy transfer. Biochem. Biophys. Acta. 1993;1144:1–16
  54. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R. New York. New York State Psychiatric Institute, Biometrics Research Department; 1987;
  55. Spratt DI, Pont A, Miller MB, McDougall IR, Bayer MF, McLaughlin WT. Hyperthyroxinemia in patients with acute psychiatric disorders. Am. J. Med. 1982;73:41–48
  56. Weiner MF. Haloperidol, hyperthyroidism and sudden death. Am. J. Psychiatry. 1979;136:717–718
  57. Whybrow PC, Coppen A, Prange AJ, Noguera R, Bailey JE. Thyroid function and the response to liothyronine in depression. Arch. Gen. Psychiatry. 1972;26:242–245

PII: S0920-9964(99)00187-5

Schizophrenia Research
Volume 44, Issue 3 , Pages 233-243 , 1 September 2000

Article Tools